- A pharma based approach to developing cannabis products for medical
and recreational markets
- Leadership team with international relationships in the fast growing medical and recreational cannabis industry
- Expertise developing innovative, effective and precise cannabidiol (CBD), terpene and tetrahydrocannabinol (THC) based products
- Seeking to acquire or develop, best in class novel technologies
and bring them to market
- Financial partners with experience in funding and creating value for shareholders in cannabis companies
Through MJ BioPharma
- Develop our own unique extracts and custom formulations with unique processes and methodologies.
- Develop and numerous edible and oil products for the Medical and Recreational space.
Through Biolennia Labs
- Carry out R&D, develop and isolate formulations for use in medical and recreational applications.
- Currently in application process for a dealers license.
- Build a California and Nevada-licensed genetics breeding facility with extraction systems.
- Add a dispensary license with our extraction and genetics partners.
Canadian Market Estimate
US Market Estimate
Market Key Facts
A revolution is taking place in North America and across the globe and the race to create a better, more sophisticated supply chain with medical grade, quality controlled, custom cannabis products is underway. MJ BioPharma is aiming to establish itself as a leader in this segment by acquiring and developing novel technologies with immediate term commercial applications.